Adult Spinal Deformity Market Report 2026

The adult spinal deformity market size has grown strongly in recent years. It will grow from $2.57 billion in 2025 to $2.73 billion in 2026 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to growing prevalence of adult spinal deformities, increasing spinal surgeries and fusion procedures, rising geriatric population, adoption of traditional spinal fixation devices, expansion of hospital-based spine care programs.

The adult spinal deformity market size is expected to see strong growth in the next few years. It will grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to development of advanced minimally invasive spinal devices, increasing awareness of spinal deformity correction options, growth in ambulatory surgical centers, rising adoption of image-guided and robotic-assisted spine surgeries, expansion of post-operative rehabilitation services. Major trends in the forecast period include increasing adoption of minimally invasive spinal surgeries, rising demand for spinal fusion and deformity correction procedures, growth in advanced cervical and thoracolumbar fixation devices, expansion of ambulatory surgical centers for spine care, enhanced focus on post-surgical rehabilitation and patient outcomes.

The rise in obesity rates is expected to drive the growth of the adult spinal deformity market going forward. Obesity rates refer to the proportion of a population classified as obese based on body mass index (BMI) measurements, generally defined as a BMI of 30 or higher. The increase in obesity is driven by higher consumption of calorie-dense, processed foods and sedentary lifestyles, along with limited access to nutritious foods and environmental factors. Adult spinal deformity treatments are increasingly used in obese patients to manage the added mechanical stress on the spine and reduce the risk and progression of spinal deformities associated with obesity. For instance, in March 2025, according to the World Obesity Federation, a UK-based membership organization, by 2030, nearly 3 billion adults, or about 50% of the global adult population, will be affected by overweight or obesity. Therefore, rising obesity rates are propelling the growth of the adult spinal deformity market.

Major companies operating in the adult spinal deformity market are focusing on developing patient-specific solutions, such as implant technologies, to address and assess congenital anomalies of the upper limb, particularly hand and wrist deformities. Spinal deformity devices integrate advanced implant materials such as titanium alloys and polymer composites to provide structural support and facilitate corrective procedures. For instance, in January 2023, Orthofix Medical Inc., a U.S.-based medical device company, launched the Mariner deformity pedicle screw system following its merger with SeaSpine. This system is designed for complex adult spinal deformity cases and features advanced reduction tools, specialized implants, and robust osteotomy instruments. Mariner’s modular technology offers a comprehensive implant solution, reducing surgical trays and improving operational efficiency in hospitals through streamlined workflows and lower costs.

In September 2023, Globus Medical Inc., a U.S.-based musculoskeletal solutions provider, merged with NuVasive Inc. for an undisclosed amount. The merger aims to combine the strengths of NuVasive and Globus Medical in advancing spinal surgery technologies and expanding market presence. This integration is expected to enhance their ability to deliver innovative and minimally invasive spinal surgery solutions, improve patient outcomes, and drive growth in the spinal surgery market. NuVasive Inc. is a U.S.-based medical device company specializing in spinal deformity treatment solutions.

Major companies operating in the adult spinal deformity market are Abbott Laboratories, Medtronic plc, Johnson & Johnson MedTech, Stryker Corporation, B Braun Melsungen AG, Zimmer Biomet Holdings Inc, NuVasive Inc, Globus Medical Inc, Medacta International, Orthofix Medical Inc, Alphatec Holdings Inc, Exactech Inc, RTI Surgical Holdings Inc, SeaSpine Holdings Corporation, Centinel Spine LLC, Spine Wave Inc, Zavation Medical Products LLC., Spinal Elements Holdings Inc., Simplify Medical Inc, Aurora Spine Corporation, Premia Spine Ltd, Innovasis Inc, Osseus Fusion Systems, SpineGuard SA.

North America was the largest region in the adult spinal deformity market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period The regions covered in the adult spinal deformity market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the adult spinal deformity market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the adult spinal deformity market by raising costs for imported spinal fixation devices, interbody fusion implants, and surgical instrumentation. Segments such as thoracolumbar and cervical fixation devices are most impacted, particularly in north america, europe, and asia-pacific regions where high import dependence exists. These tariffs have increased procurement costs and slowed device adoption. On the positive side, tariffs have incentivized local manufacturing and innovation in device design, fostering domestic production capabilities.

The adult spinal deformity market research report is one of a series of new reports that provides adult spinal deformity market statistics, including adult spinal deformity industry global market size, regional shares, competitors with a adult spinal deformity market share, detailed adult spinal deformity market segments, market trends and opportunities, and any further data you may need to thrive in the adult spinal deformity industry. This adult spinal deformity market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Adult spinal deformity is an abnormal curvature of the spine that develops or persists in adulthood, such as scoliosis (sideways curve), kyphosis (rounded back), or lordosis (excessive lower back curve). It can lead to pain and functional difficulties and may require treatment through physical therapy, medications, or surgery.

The main product types of adult spinal deformities include scoliosis, kyphosis, and lordosis. Scoliosis is a condition in which the spine curves sideways, forming an 'S' or 'C' shape, causing uneven shoulders, hips, and back pain. Treatments aim to correct or manage these spinal curves to improve function and reduce discomfort. The product types include cervical fixation devices, interbody fusion devices, thoracolumbar devices, and others. The procedures include spinal fusion surgery, osteotomy, spinal deformity correction, spinal arthrodesis, spinal fixation, minimally invasive spinal surgeries, and others, with applications in hospitals and clinics, ambulatory surgical centers, and other healthcare settings.

The adult spinal deformity market consists of revenues earned by entities by providing services such as diagnostic imaging, surgical interventions (including spinal fusion and corrective surgeries), non-surgical treatments (such as physical therapy and bracing), and ongoing patient management and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The adult spinal deformity market also includes sales of spinal implants (including screws, rods, and cages), orthotic braces, surgical instruments, and diagnostic tools (such as X-ray and MRI machines). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.